Yangyang Liu

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Vascular Endothelial Growth Factor

Anti Inflammatory

Room Temperature

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Yangyang Liu, Dong-Sheng Zhao, Chenghua Zhang, Hui Fang, Qingsitong Shen, Zhixian Wang, Jiangying Cao
Development of Hydroxamate Derivatives Containing a Pyrazoline Moiety as APN Inhibitors to Overcome Angiogenesis. Molecules (Basel, Switzerland) 27 (23) (2022)
Yangyang Liu, Dong-Sheng Zhao, Chenghua Zhang, Hui Fang, Qingsitong Shen, Zhixian Wang, Jiangying Cao
Development of Hydroxamate Derivatives Containing a Pyrazoline Moiety as APN Inhibitors to Overcome Angiogenesis. Molecules (Basel, Switzerland) 27 (23) (2022)
Yangyang Liu, Dong-Sheng Zhao, Chenghua Zhang, Hui Fang, Qingsitong Shen, Zhixian Wang, Jiangying Cao
Development of Hydroxamate Derivatives Containing a Pyrazoline Moiety as APN Inhibitors to Overcome Angiogenesis. Molecules (Basel, Switzerland) 27 (23) (2022)
Yangyang Liu, Dong-Sheng Zhao, Chenghua Zhang, Hui Fang, Qingsitong Shen, Zhixian Wang, Jiangying Cao
Development of Hydroxamate Derivatives Containing a Pyrazoline Moiety as APN Inhibitors to Overcome Angiogenesis. Molecules (Basel, Switzerland) 27 (23) (2022)